Physician profile
Andrew A Chi
NPI 1952517054
$4,384.63
in general payments reported to CMS, 2019-2025
30 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2021: $1,117 · 2022: $1,029 · 2023: $1,196 · 2024: $527 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.76 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,162.37 | 2021-2022 | |
| Astellas Pharma US INC | $790.92 | 2022-2025 | Xtandi |
| Boston Scientific Corporation | $345.22 | 2022-2024 | Lithovue, Upsylon, Solyx Sis System |
| Teleflex LLC | $276.11 | 2023-2024 | Urolift, Solesta |
| Antares Pharma, INC. | $218.92 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $185.10 | 2023-2024 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $160.62 | 2022 | |
| Abbvie INC. | $147.75 | 2024-2025 | |
| Dornier Medtech America, INC | $136.57 | 2023 | Dornier Medtech |
| Laborie Medical Technologies Corp. | $126.80 | 2023-2024 | Urgent PC Neuromodulation System |
| Medtronic USA, INC. | $112.93 | 2019 | |
| Pfizer INC. | $94.60 | 2023-2024 | |
| Coloplast Corp | $88.92 | 2021-2024 | |
| Janssen Biotech, INC. | $87.03 | 2021-2024 | Erleada |
| Allergan, INC. | $63.54 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $52.13 | 2023-2025 | Keytruda, Lynparza |
| Halozyme INC | $51.72 | 2023 | |
| Procept Biorobotics Corporation | $40.61 | 2023 | Aquabeam Robotic System |
| Kowa Pharmaceuticals America, INC. | $30.51 | 2022 | |
| 180 Medical, INC. | $25.67 | 2022 | |
| Angiodynamics, INC. | $24.81 | 2022 | |
| Olympus America INC. | $23.49 | 2024 | Itind System |
| Telix Pharmaceuticals | $20.30 | 2024 | Illuccix |
| Palette Life Sciences, INC. | $20.29 | 2023 | |
| Photocure INC | $19.78 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $18.68 | 2023 | Bard Urinary Drainage Bag |
| Ambu INC. | $16.39 | 2022 | |
| Davol INC. | $15.73 | 2025 | Arista |
| Axonics, INC. | $13.89 | 2021 | |
| Therapeuticsmd, INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.